drug

echinocandin

1 story · latest Aug 10, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by Scynexis Inc

Timeline

Scynexis posts results for terminated Phase 3 MARIO trial in invasive candidiasis

Aug 10Trial updateechinocandin Scynexis Inc

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.